{"mainPropery":{"diseaseId":12588,"diseaseName":"Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12588/congenital-muscular-alpha-dystroglycanopathy-with-brain-and-eye-anomalies","synonyms":["Lissencephaly type 2 with muscular and ocular involvement","MDDGA"],"synonyms-with-source":[{"name":"Lissencephaly type 2 with muscular and ocular involvement","source":"MDDGA"},{"name":"MDDGA","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"352687"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=352687' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:352687' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies:<br />\r\n<a href='https://www.cmdir.org/' target='_blank'>Congenital Muscle Disease International Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12589,"relatedDiseaseName":"Congenital muscular dystrophy-dystroglycanopathy with or without intellectual disability (type B)","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":6475,"relatedDiseaseName":"Fukuyama type muscular dystrophy","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":156,"relatedDiseaseName":"Muscle eye brain disease","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":2599,"relatedDiseaseName":"Walker-Warburg syndrome","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Congenital_muscular_alpha-dystroglycanopathy_with_brain_and_eye_anomalies"}